Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Neuropharmacol. 2003 Jul-Aug;26(4):218-21.

Metabolite changes resulting from treatment in children with ADHD: a 1H-MRS study.

Author information

  • 1Maritime Psychiatry, IWK Health Centre, 5850 University Avenue, Halifax, Nova Scotia, Canada B3J 3G9. Normand.Carrey@iwk.nshealth.ca

Abstract

Previously the authors noted an increase in glutamatergic tone in children with attention deficit hyperactivity disorder compared with age- and gender-matched control subjects. In this study they examine the effect of treatment on metabolite concentrations. Fourteen children with attention deficit hyperactivity disorder were investigated medication free and after treatment, using proton magnetic resonance spectroscopy. In the prefrontal cortex and striatum, metabolite peaks of N-acetyl-aspartate, glutamate/glutamine/gamma-aminobutyric acid, creatine/phosphocreatine, and choline compounds were measured, and ratios of the peaks were calculated and compared before and after treatment. The glutamate/glutamine/gamma-aminobutyric acid-to-creatine/phosphocreatine ratio decreased significantly in the striatum. No other metabolites demonstrated any change in response to medication. These findings suggest that glutamate may be involved in treatment response in attention deficit hyperactivity disorder, especially in the striatum.

PMID:
12897644
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Lippincott Williams & Wilkins
    Loading ...
    Write to the Help Desk